Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

As shown in Table 1, 25(OH)D concentrations were higher in women who were older, thinner, never smoked, had a higher level of education, lived in the highest SES neighborhoods, and provided a blood sample during the summer months.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Women were specifically asked whether they had ever had a COVID-19 test, and the results of the test (positive, negative, unsure).

Source: Methods.

We conducted a sub-analysis of “severe” or “long-haul” COVID-infection restricted to the 41 women who reported that they had been hospitalized for COVID-19 or that their health had not returned to the usual level it had been before they had become infected.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women

Secondary analysis · PLoS ONE · 2021

Original publication title

Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women

Yvette C. Cozier; Nelsy Castro-Webb; Natasha S. Hochberg; Lynn Rosenberg; Michelle A. Albert; Julie R. Palmer

© 2021 Cozier et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The present results suggest that U.S. Black women with lower levels of 25(OH)D are at increased risk of infection with COVID-19. Further work is needed to confirm these findings and determine the optimal level of 25(OH)D for a beneficial effect.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Limited evidence suggests that higher levels of serum vitamin D (25(OH)D) protect against SARS-CoV-2 virus (COVID-19) infection. Black women commonly experience 25(OH)D insufficiency and are overrepresented among COVID-19 cases. We conducted a prospective analysis of serum 25(OH)D levels in relation to COVID-19 infection among participants in the Black Women’s Health Study.

Source: Objective

Abstract: What methods does the paper describe?

Since 1995, the Black Women’s Health Study has followed 59,000 U.S. Black women through biennial mailed or online questionnaires. Over 13,000 study participants provided a blood sample in 2013 to 2017. 25(OH)D assays were performed in a certified national laboratory shortly after collection of the samples. In 2020, participants who had completed the online version of the 2019 biennial health questionnaire were invited to complete a supplemental online questionnaire assessing their experiences related to the COVID-19 pandemic, including whether they had been tested for COVID-19 infection and the result of the test.

We used logistic regression analysis to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association of 25(OH)D level with COVID-19 positivity, adjusting for age, number of people living in the household, neighborhood socioeconomic status, and other potential confounders.

Source: Methods

Abstract: Results

Among 5,081 eligible participants whose blood sample had been assayed for 25(OH)D, 1,974 reported having had a COVID-19 test in 2020. Relative to women with 25(OH)D levels of 30 ng/mL (75 nmol/l) or more, multivariable-adjusted ORs for COVID-19 infection in women with levels of 20 to 29 ng/mL (50 to 72.5 nmol/l) and <20 ng/mL (<50 nmol/l) were, respectively, 1.48 (95% CI 0.95 to 2.30) and 1.69 (95% CI 1.04 to 2.72) (p trend 0.02).

Source: Results

Abstract: Conclusion

The present results suggest that U.S. Black women with lower levels of 25(OH)D are at increased risk of infection with COVID-19. Further work is needed to confirm these findings and determine the optimal level of 25(OH)D for a beneficial effect.

Source: Conclusion
Authors’ abstract

Objective

Limited evidence suggests that higher levels of serum vitamin D (25(OH)D) protect against SARS-CoV-2 virus (COVID-19) infection. Black women commonly experience 25(OH)D insufficiency and are overrepresented among COVID-19 cases. We conducted a prospective analysis of serum 25(OH)D levels in relation to COVID-19 infection among participants in the Black Women’s Health Study.

Methods

Since 1995, the Black Women’s Health Study has followed 59,000 U.S. Black women through biennial mailed or online questionnaires. Over 13,000 study participants provided a blood sample in 2013 to 2017. 25(OH)D assays were performed in a certified national laboratory shortly after collection of the samples. In 2020, participants who had completed the online version of the 2019 biennial health questionnaire were invited to complete a supplemental online questionnaire assessing their experiences related to the COVID-19 pandemic, including whether they had been tested for COVID-19 infection and the result of the test.

We used logistic regression analysis to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association of 25(OH)D level with COVID-19 positivity, adjusting for age, number of people living in the household, neighborhood socioeconomic status, and other potential confounders.

Results

Among 5,081 eligible participants whose blood sample had been assayed for 25(OH)D, 1,974 reported having had a COVID-19 test in 2020. Relative to women with 25(OH)D levels of 30 ng/mL (75 nmol/l) or more, multivariable-adjusted ORs for COVID-19 infection in women with levels of 20 to 29 ng/mL (50 to 72.5 nmol/l) and <20 ng/mL (<50 nmol/l) were, respectively, 1.48 (95% CI 0.95 to 2.30) and 1.69 (95% CI 1.04 to 2.72) (p trend 0.02).

Conclusion

The present results suggest that U.S. Black women with lower levels of 25(OH)D are at increased risk of infection with COVID-19. Further work is needed to confirm these findings and determine the optimal level of 25(OH)D for a beneficial effect.

Publication and source details

Original title: Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women

Yvette C. Cozier; Nelsy Castro-Webb; Natasha S. Hochberg; Lynn Rosenberg; Michelle A. Albert; Julie R. Palmer

PLoS ONE · 2021

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: yvettec@bu.edu
© 2021 Cozier et al2021Cozier et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/100011541Division of Cancer Epidemiology and Genetics, National Cancer Institute R01: CA058420 Rosenberg Lynn http://dx.doi.org/10.13039/100011541Division of Cancer Epidemiology and Genetics, National Cancer Institute U01-CA164974 Palmer Julie R. http://dx.doi.org/10.13039/100000968American Heart Association 12174sc Albert Michelle A. http://dx.doi.org/10.13039/100000968American Heart Association 12174sc https://orcid.org/0000-0003-0625-7256 Cozier Yvette C. Research reported in this publication was supported by the National Cancer Institute (www.cancer.gov) R01-CA058420 (PI: Rosenberg); U01-CA164974 (PIs: Palmer, Rosenberg); and the American Heart Association (www.heart.org) 12174sc (PIs: Albert, Cozier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T12:55:41.850387+00:00

DOI: 10.1371/journal.pone.0255132 · PMC8315514